TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $95,652 | +108.0% | 6,183 | +111.2% | 0.00% | – |
Q2 2023 | $45,984 | -8.7% | 2,927 | -4.3% | 0.00% | -100.0% |
Q1 2023 | $50,380 | +15.7% | 3,057 | +9.5% | 0.00% | – |
Q4 2022 | $43,540 | +17.7% | 2,791 | -2.8% | 0.00% | – |
Q3 2022 | $37,000 | +362.5% | 2,871 | +435.6% | 0.00% | – |
Q2 2022 | $8,000 | +700.0% | 536 | +665.7% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | -75.0% | 70 | -64.3% | 0.00% | – |
Q2 2020 | $4,000 | +300.0% | 196 | +180.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 70 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |